Erratum: Multigene Panel Testing in a Large Cohort of Adults With Epilepsy: Diagnostic Yield and Clinically Actionable Genetic Findings

Abstract

[This corrects the article DOI: 10.1212/NXG.0000000000000650.].

Figure 4. Clinically Actionable Genetic Findings, Overall and Among Individuals With Pharmacoresistant Seizures

(A) All definitive molecular diagnoses and (B) definitive molecular diagnoses with pharmacoresistant seizures were categorized according to whether the diagnostic finding was in a gene with a published clinical action and if so, the type (ASM indications, ASM contraindications, metabolic treatments, possible surgical indications, or surgical contraindications). Individuals with clinically actionable findings in more than 1 category were counted more than once. A full list of clinically actionable genetic findings can be found in eTable 3 (links.lww.com/NXG/A505). ASM = antiseizure medication.